Menu
ncarol.com
  • Home
  • Music
  • Asheville Music
  • Entertainment
  • Business
  • Real Estate
  • Technology
  • Health
  • Non-profit
ncarol.com

Lenoir NC Company Files US Patent Application for "Voice-Activated Talk-Through Safety Mask Appliance and Method" dubbed, "VATTSMA™"
ncarol.com/10061312

Trending...
  • Philadelphia-Area Entrepreneur Nouho M Kanneh Builds $37 Million Net Worth Across Real Estate, E-Commerce and Retail
  • Jamie Foxx's SKVLK Fest Sets the Record Straight on Stabbing Reports Following Star-Studded Celebration
  • Andrew Balzano Releases One of My Life's Passions: Classics and Mysteries, a Fan's Guide to Great Mysteries Worth Rewatching
Inventors find 'Silver Lining in COVID-19 Cloud' with New Talk-Through Face Mask, Miniature Loudspeaker and Telecommunications Emitter Developed at University of Pittsburgh

KITTY HAWK, N.C. - ncarol.com -- Joyce Mann, Chairman and CEO of Lenoir-based RMANNCO, Inc., announced today that RMANNCO, Inc. has caused the formal filing of Letters Patent Application drawn to a new means and method of communication and biocontrol protection while wearing any kind of face covering, such as surgical masks, plastic face shields or cloth face.  The title of the invention is "Voice-Activated Talk-Through Safety Mask Appliance and Method", called, 'VATTSMA'™. See: https://doctorjoesoriginal.weebly.com/  The Inventors listed on the patent application are Ms. Joyce M. Mann and Dr. Joseph A. Resnick.

The new product has its foundations in three early patents issued by inventor, Resnick, while a student at the University of Pittsburgh Eye and Ear Hospital, Pittsburgh, PA where he developed 'The Resnick Tone Emitter', known as the 'Talking-Tooth', which issued as US Patent #4,571,739, Intraoral Electrolarynx; US Patent #4,706,292, Speech Prosthesis; and US Patent #5,015,179 Speech Monitor. See: https://tinyurl.com/y742blc7 . Dr. Joe Resnick, a former NASA Scholar and Research Scientist, said, "Parts of those prior technologies are used in the new VATTSMA™ product for which letters patent protection is pending approval.  Of particular value and use for the new product is the miniature loudspeaker and electronics 'chip' we developed at Pitt in the 1980's, as these are 'fluid-resistant' and won't be affected by moisture from breathing, talking, etc.  A value-added feature is that the electronics package is removable allowing its use on new masks once original masks have become soiled or unwanted".  Resnick continued, "As an 'Optimist', I like to find good outcomes in everything…even worst-case scenarios such as the COVID-19 Pandemic. I have always been aware of the problems communicating while wearing a surgical-type mask.  This was problematic when I was a student at Pitt, nearly 40 years ago…and has remained problematic to this day…even in my own work in my own laboratory.  Enter the new VATTSMA™ technology.  Now, people wearing masks equipped with the amplification emitter who work in health care, in hospitals, etc., or government officials giving speeches or having to talk in public, will be able to do so without removing the mask and their speech will be more intelligible, more audible at 83 dB, which is just a little louder than speech during normal communication. So, to quote the old sayings, 'Every cloud has a silver lining'.  And the VATTSMA™ technology represents a little piece of 'silver lining' that we have realized necessary and which fills a real-world need, despite this horrible Pandemic. 'Fortune favors the Bold'".

More on ncarol.com
  • Kitchen Table Economics: An Invitation to Think Differently
  • Gabby Press Earns High Praise From BookLife For Book About the Dangers of Corporate AI
  • Win a $5,000 VIP Family Experience at the 100th Thanksgiving Day Parade in New York City
  • CB Stuffer Announces Private Sale to Secure Future of Brand Growth
  • The Fifth Annual "Bamboo Lantern Festival" to Illuminate Tokyo Mizumachi and Sumida River Walk®

Since the declaration of the COVID-19 Pandemic by the World Health Organization in March 2020, most of the world's population has resorted to, or been mandated to, wearing some form of mask or face covering thought to help slow/stop the spread of the Corona Virus, COVID-19.  According to the US Department of Commerce more than 2 Billion safety masks have been produced and used since the outbreak of the Corona Virus in January 2020. The US Department of Commerce reports that more than 300 Million N-95 masks have been ordered by various US government agencies since March 2020 with the US Military ordering millions more.

Mann said that the initial price for the individual VATTSMA™ unit will be around $20.00, and that a test-market study is being orchestrated on the 'GoFundMe' Crowdfunding platform at https://tinyurl.com/yau4duub .  Mann said, "That price should drop, significantly, as large orders are received and the units can be contracted and sold at retail by the tens-of-thousands".  Mann said, "Yes, they may seem a bit pricey, at first.  But the retail price will fall, a function of supply and demand economics.  As we receive more and more orders and these are passed along to our manufacturers, the electronics component price will fall, drastically.  When that happens we will be able to offer the technology/masks for about the same retail price as an N-95 mask today".

Mann said that RMANNCO, Inc., Licensee to the technology, is actively seeking JV partners to assist with global marketing of the VATTSMA™ product line because the potential market size is so large.

More on ncarol.com
  • Apex Wellness Architect Hosts Intimate Tea & Intentions Tea Bar Experience to Close Out the Year
  • Iglesia.com Positioned in Multimillion-Dollar Domain Market with $10 Million Asking Price
  • TCA VG: 2025 Funding Climbs to $9M across 43 Companies; Cumulative Returns Reach 5.3 MOIC & 22% IRR
  • Searching for the Next LBE Creator: CalArts Launches First-Ever D.R.E.A.M.S. Pitch Competition
  • Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales

END

For Additional Information Contact:

Ms. Joy Mann, Chief Executive Officer
Email: Joy@rmannco.com
Phone: 478-244-2131
www.rmannco.com

Contact
RMANNCO, Inc.
Joyce M. Mann, CEO
nxgenusa@aol.com
8285727705


Source: RMANNCO, Inc.

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Lake Norman Philharmonic - Free Holiday Concert
  • S&P 500's 4.4% Plunge: Buy the Dip or Wait? KayeDinero Spotlights TrendSetter
  • Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand
  • Kestrel Ridge Health Launches AI-Powered Ophthalmology Workforce Forecasting Platform
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • Brian G. Miller Co., LLC Receives Tier 1 Ranking in the 2027 Edition of Best Law Firms®
  • The Villari Firm, PLLC Named to the 2027 Edition of Best Law Firms
  • Bacchus Wine & Spirits and Michelin Guide–Recommended Ethel's Fancy to Host Exclusive LOUIS XIII Limited Edition Diwali Decanter Celebration
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
  • ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • Genuine Hospitality, LLC Selected to Operate Holiday Inn Express & Suites Jacksonville – Town Center
  • Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
  • Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
  • PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
  • Tonight in Asheville: KayeDinero Drops "Underground" and Opens Beat Catalog
  • KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
  • Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • Prince's Collaborator Shelby J To Be A Special Guest For "a Deadly Proposal" Red Carpet
_catLbl0 _catLbl1

Popular on ncarol.com

  • Parade of Homes Winners Announced - 264
  • Nious Media Expands Independent Entertainment Network Through Gaming, Music and Digital Storytelling - 198
  • North Carolina Author Carrie Sybert Celebrates Three Published Books - 184
  • Kestrel Ridge Health Launches AI-Powered Ophthalmology Workforce Forecasting Platform - 132
  • Air Force Veteran Sean Douglas Delivers Powerful Suicide Prevention Presentations to Hundreds of Marines at Camp Pendleton - 130
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki - 126
  • 450 Million Revenue Run Rate, Global Telecom Reach and a New Digital Growth Opportunity Take Center Stage: IQSTEL, Inc. (N A S D A Q: IQST) - 118
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs - 118
  • Renew Integrative Health Publishes Updated Peptide Therapy Guide to Help Patients Understand Their Options - 115
  • UK Financial Ltd Announces Two-for-One Upgrade of Maya 3 to Maya 3G Token Using Chainlink Cross-Chain Technology - 112

Similar on ncarol.com

  • Contracting Resources Group Receives 2026 HIRE Vets Platinum Medallion Award
  • Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
  • Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
  • Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute